Targeting TRIP13 in Wilms Tumor with Nuclear Export Inhibitors
Karuna Mittal(Emory University), Andrew L. Hong(Broad Institute)
Cited by 5
Related Papers
Integrated genetic and pharmacologic interrogation of rare cancers
|Nature Communications|2016|56
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
|Communications Biology|2024|9
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2018|0